Cargando…
Germline PRDM1 Variant rs2185379 in Long-Term Recurrence-Free Survivors of Advanced Ovarian Cancer
PURPOSE: To identify the germline genetic characteristics of long-term recurrence-free survivors that can be applied to establishing a new strategy for curing advanced cancer, we investigated the whole-genome single nucleotide variants of ovarian cancer patients. PATIENTS AND METHODS: DNA specimens...
Autores principales: | Mitamura, Takashi, Zhai, Tianyue, Hatanaka, Kanako C, Hatanaka, Yutaka, Amano, Toraji, Wang, Lei, Tanaka, Shinya, Watari, Hidemichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719363/ https://www.ncbi.nlm.nih.gov/pubmed/36471864 http://dx.doi.org/10.2147/PGPM.S387120 |
Ejemplares similares
-
Genetic heterogeneity during breast cancer progression in young patients
por: Hagio, Kanako, et al.
Publicado: (2021) -
Combination therapy with bevacizumab and a CCR2 inhibitor for human ovarian cancer: An in vivo validation study
por: Zhai, Tianyue, et al.
Publicado: (2023) -
The prognosis of endometrial cancers stratified with conventional risk factors and modified molecular classification
por: Yamazaki, Hiroyuki, et al.
Publicado: (2022) -
Clusterin is a potential molecular predictor for ovarian cancer patient's survival: targeting Clusterin improves response to paclitaxel
por: Hassan, Mohamed K, et al.
Publicado: (2011) -
Assessment for the timing of comprehensive genomic profiling tests in patients with advanced solid cancers
por: Hagio, Kanako, et al.
Publicado: (2023)